Pfizer Reaches Deal on Most-Favored Nation Drug Pricing; Other Pharmas Expected to Follow
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations,…
Pfizer Reaches Deal on Most-Favored Nation Drug Pricing; Other Pharmas Expected to Follow
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue. The post Pfizer Reaches Deal on Most-Favored Nation Drug Pricing;…
Two trends: Global pricing and ‘Pharm-to-table’
EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…
Millie Introduces Perimenopause and Menopause Program
With Millie’s new perimenopause and menopause offerings, patients receive treatments like hormone therapy, non-hormonal medications, vaginal treatments and lifestyle strategies for symptom relief. The post Millie Introduces Perimenopause and Menopause Program appeared first on MedCity News.
Millie Introduces Perimenopause and Menopause Program
With Millie’s new perimenopause and menopause offerings, patients receive treatments like hormone therapy, non-hormonal medications, vaginal treatments and lifestyle strategies for symptom relief. The post Millie Introduces Perimenopause and Menopause Program appeared first on MedCity News.
MedCity FemFwd: How Evvy Is Advancing Women’s Health Research
In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network. The post MedCity FemFwd: How Evvy Is Advancing Women’s Health…
MedCity FemFwd: How Evvy Is Advancing Women’s Health Research
In this episode, we’re joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women’s health research and what she hopes to achieve as a founding member of the Milken Institute’s Women’s Health Network. The post MedCity FemFwd: How Evvy Is Advancing Women’s Health…
Startup Crystalys Therapeutics Emerges With $205M to Fill a Growing Gap in Gout Treatment
Crystalys Therapeutics’ gout drug, dotinurad, inhibits a known and validated target for treating the chronic disorder, but in a way that could be safer than other drugs. The oral small molecule was discovered and developed in Japan, where it is approved and has a safety record spanning more than 1 million gout patients. The post…
The Best 3 Spine Specialists in Hershey, PA
[Sponsored] Selecting a specialist in spine care requires careful evaluation. If you are looking for an experienced spine specialist in Hershey or the surrounding area, consider these top three practices. The post The Best 3 Spine Specialists in Hershey, PA appeared first on MedCity News.
El crecimiento del empleo en salud se ve empañado por medidas contra inmigrantes y recortes a Medicaid
El sector de la salud ha sido un punto positivo en la economía este año, representando casi la mitad del crecimiento del empleo en el país. Sin embargo, economistas y expertos advierten que las políticas contra inmigrantes y los recortes a Medicaid podrían poner en riesgo ese crecimiento en el futuro. De enero a agosto,…
ACA Marketplace Premium Payments Would More than Double on Average Next Year if Enhanced Premium Tax Credits Expire
KFF estimates that, if Congress allows the enhanced premium tax credits to expire at the end of this year, ACA Marketplace enrollees on average would see their premium payments more than double next year, growing by 114%, from an average of $888 in 2025 to $1,904 in 2026,
